1-1 of 1
Ann Maclaren, PhD BS
Close
Sort by
Journal Articles

Trph-222, a Novel Anti-CD22 Antibody Drug Conjugate (ADC), Has Signficant Anti-Tumor Activity in NHL Xenografts and Is Well Tolerated in Non-Human Primates

Ann Maclaren, PhD BS, Nancy Levin, PhD, Henry Lowman, PhD, Mohit Trikha, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4105.
https://doi.org/10.1182/blood.V130.Suppl_1.4105.4105
Published: 2017